Menu
← Oncology Approval Tracker
FDA DECISION ·
Fyarro
sirolimus protein-bound particles (albumin-bound) · Aadi Bioscience
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor.
LAMPGEN ANALYSIS
Why it matters
This approval establishes a systemic option for a rare sarcoma with a distinct formulation of sirolimus.
What research teams should watch
Use histology review to confirm malignant PEComa and capture when surgery was deemed infeasible.
PRIMARY RECORDS